Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
49.42
+2.47 (5.26%)
Nov 17, 2026, 3:04 PM CST

Intco Medical Technology Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
13,0549,8609,4366,8876,59116,217
Other Revenue
66.2666.2687.3331.3623.2123.28
13,1209,9269,5236,9196,61416,240
Revenue Growth
33.20%4.23%37.65%4.61%-59.27%17.37%
Cost of Revenue
8,8227,5527,3475,9765,7766,267
Gross Profit
4,2982,3742,176942.35837.659,973
Selling, General & Admin
1,134984.19806.58738.31614.49929.36
Research & Development
507.9404.38398.34283.37252.32365.22
Other Operating Expenses
113.727545.3667.2955.3944.07
Operating Expenses
1,7671,4651,2741,105907.941,390
Operating Income
2,531909901.75-162.49-70.288,583
Interest Expense
-373.54-369.15-308.04-127.74-28.46-17.61
Interest & Investment Income
524.78747.65596.53396.16193.48172.61
Currency Exchange Gain (Loss)
-401.18-401.18225.49133.39548.96-103.86
Other Non Operating Income (Expenses)
-329.41-6.78-23.13-16.42-8.61-10.45
EBT Excluding Unusual Items
1,952879.541,393222.9635.098,624
Gain (Loss) on Sale of Investments
-1,316318.5279.77175.5759.6732.66
Gain (Loss) on Sale of Assets
-0.28-0.40.220.212.370.38
Asset Writedown
26.023.18-88.8-21.32-26.87-29.04
Other Unusual Items
28.9228.9225.1365.4634.1521.07
Pretax Income
690.661,2301,609442.82704.418,649
Income Tax Expense
308.73182.55117.2354.7565.071,185
Earnings From Continuing Operations
381.931,0471,492388.06639.347,463
Minority Interest in Earnings
-83.48-36.49-26.21-5.07-10.27-33.4
Net Income
298.441,0111,465383629.077,430
Net Income to Common
298.441,0111,465383629.077,430
Net Income Growth
-82.47%-31.03%282.63%-39.12%-91.53%6.04%
Shares Outstanding (Basic)
644640648660662656
Shares Outstanding (Diluted)
648644648660662675
Shares Change
1.93%-0.72%-1.80%-0.28%-1.97%9.01%
EPS (Basic)
0.461.582.260.580.9511.33
EPS (Diluted)
0.461.572.260.580.9511.00
EPS Growth
-82.80%-30.53%289.65%-38.95%-91.36%-2.73%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,788-689.72-710.37-936.28-649.763,236
Free Cash Flow Per Share
2.76-1.07-1.10-1.42-0.984.79
Dividend Per Share
0.2000.1500.1500.0800.0990.625
Dividend Growth
33.33%0%87.50%-19.00%-84.20%-66.25%
Gross Margin
32.76%23.91%22.85%13.62%12.67%61.41%
Operating Margin
19.29%9.16%9.47%-2.35%-1.06%52.85%
Profit Margin
2.27%10.18%15.39%5.54%9.51%45.75%
Free Cash Flow Margin
13.63%-6.95%-7.46%-13.53%-9.82%19.93%
EBITDA
3,5731,8731,761557.08556.798,950
EBITDA Margin
27.23%18.87%18.50%8.05%8.42%55.11%
D&A For EBITDA
1,042963.9859.74719.57627.08367.24
EBIT
2,531909901.75-162.49-70.288,583
EBIT Margin
19.29%9.16%9.47%-2.35%-1.06%52.85%
Effective Tax Rate
44.70%14.85%7.29%12.37%9.24%13.70%
Revenue as Reported
13,1209,9269,5236,9196,61416,240
Advertising Expenses
-18.7718.9232.9817.8591.6